Lung cancer vaccine CIMAvax-EGF stands out at BioHabana 2022
Havana, April 28
The clinical trial results with Cuban lung cancer vaccine CIMAvax-EGF on Thursday stands out in the theoretical sessions of the BioHabana 2022 International Congress, scheduled until Friday, April 29.
Dr. Tania Crombet, a Clinical Research Director at the Center for Molecular Immunology (CIM), will address the efficacy of the vaccine in its phases II/III on the island, according to the program released by the organizers.




